-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$990,240 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$18.24 M
Akero Therapeutics, Inc. Insider Transactions
Akero Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Rolph Timothy
Chief Scientific Officer |
Sell | 2,380 @ $22.64 | $53,886 | 180,178 | 06/11/2024 | 06/13/2024 | |
|
Lamy Patrick
Senior VP, Commercial Strategy |
Sell | 569 @ $22.64 | $12,883 | 18,562 | 06/11/2024 | 06/13/2024 | |
|
Cheng Andrew
CEO |
Sell | 7,894 @ $22.64 | $178,728 | 581,553 | 06/11/2024 | 06/13/2024 | |
|
Young Jonathan
COO |
Sell | 5,000 @ $19.29 | $96,440 | 253,306 | 06/03/2024 | 06/05/2024 | |
|
Young Jonathan
COO |
Sell | 5,000 @ $20.15 | $100,750 | 258,306 | 05/01/2024 | 05/02/2024 | |
|
Young Jonathan
COO |
Sell | 400 @ $25.03 | $10,010 | 263,306 | 04/01/2024 | 04/03/2024 | |
|
Young Jonathan
COO |
Sell | 4,600 @ $24.33 | $111,903 | 263,706 | 04/01/2024 | 04/03/2024 | |
|
Yale Catriona
Chief Development Officer |
Sell | 723 @ $28.33 | $20,483 | 77,692 | 03/13/2024 | 03/15/2024 | |
| Sell | 724 @ $28.33 | $20,511 | 49,630 | 03/13/2024 | 03/15/2024 | ||
|
Cheng Andrew
CEO |
Sell | 1,969 @ $28.33 | $55,782 | 589,447 | 03/13/2024 | 03/15/2024 | |
|
Young Jonathan
COO |
Sell | 651 @ $28.33 | $18,443 | 268,306 | 03/13/2024 | 03/15/2024 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 619 @ $28.33 | $17,536 | 182,558 | 03/13/2024 | 03/15/2024 | |
|
Cheng Andrew
CEO |
Sell | 35,827 @ $31.40 | $1.12 M | 630,589 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 6,770 @ $32.28 | $218,538 | 623,819 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 9,614 @ $33.83 | $325,267 | 614,205 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 14,680 @ $34.63 | $508,373 | 599,525 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 7,995 @ $35.49 | $283,775 | 591,530 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 114 @ $36.28 | $4,136 | 591,416 | 03/04/2024 | 03/06/2024 | |
|
Yale Catriona
Chief Development Officer |
Sell | 20,646 @ $35.49 | $732,727 | 78,415 | 03/04/2024 | 03/06/2024 | |
|
Young Jonathan
COO |
Sell | 5,414 @ $24.00 | $129,936 | 185,131 | 12/27/2023 | 12/29/2023 |
Akero Therapeutics, Inc. Frequently Asked Questions
-
Who is on Akero Therapeutics, Inc.'s Insider Roster?
The list of insiders at Akero Therapeutics, Inc. includes Cheng Andrew, Graham G. Walmsley, Rolph Timothy, Young Jonathan, White William Richard, Yale Catriona, Lamy Patrick.
-
How much insider selling is happening at Akero Therapeutics, Inc.?
Insiders have sold a total of 639,196 Akero Therapeutics, Inc. shares in the last 12 months for a total of 18.24 M sold.
-
Which Akero Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Akero Therapeutics, Inc. shares in the last 12 months: Cheng Andrew ($6.20 M), Rolph Timothy ($96,151), Young Jonathan ($2.42 M), White William Richard ($6.58 M), Yale Catriona ($2.93 M), Lamy Patrick ($12,883),
-
How much insider buying is happening at Akero Therapeutics, Inc.?
Insiders have purchased a total of 50,000 Akero Therapeutics, Inc. shares in the last 12 months for a total of 990,240 sold.
-
Which Akero Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Akero Therapeutics, Inc. shares in the last 12 months: Graham G. Walmsley ($990,240),